Company profile
Green Growth Brands Inc.
OTC: GGBXF · Healthcare · Drug Manufacturers - Specialty & Generic
#579 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 21
v0.1 · 5/100 weight · pillars only
↑ return on assets, balance-sheet leverage · ↓ market scale, disclosure history
Methodology →Revenue TTM
$15.7M
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$64.3M
Employees
5
as of 2026-08-03
Market cap
$2.1k
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$15.7M$15.7M2018
Net income-$64.3M-$64.3M2018
Operating income-$50.5M-$50.5M2018
Total assets$150.4M$150.4M2018
Liabilities$107.9M$107.9M2018
Equity$39.8M$39.8M2018
Revenue trend
FY2016 – FY2018 · USD
FY16
FY17
FY18
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Green Growth Brands Inc.’s revenue?
Green Growth Brands Inc. booked $15.7M in FY2018 revenue — among the slowest-growing Healthcare companies we track, at a -408.5% net margin.
Peers · Healthcare
FOXO Technologies Inc.41DProfound Medical Corp.44DPatient Portal Technologies, Inc.——Neuphoria Therapeutics Inc.44DRelay Therapeutics, Inc.57CAllurion Technologies Inc.26DNeighbors
Franklin →Key facts
CEOEd Kistner
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersColumbus, OH
ExchangeOTC: GGBXF
Employees5
IPO date2018-05-15
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.